During the past decade, Adana Acıbadem Hospital Oncology Department conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 2 clinical trials were completed, i.e. on average, 11.8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 1 clinical trials were completed. i.e. 9.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Adana Acıbadem Hospital Oncology Department" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Adana Acıbadem Hospital Oncology Department" #1 collaborator was "Acıbadem Adana Hospital" with 1 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator and "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Adana Acıbadem Hospital Oncology Department" are "Hemophilia A" (4 trials), "Hemophilia B" (2 trials), "Acute Lymphoblastic Leukemia (ALL)" (1 trials), "Biliary Tract Cancer" (1 trials) and "Blood Coagulation Disorder" (1 trials). Many other conditions were trialed in "Adana Acıbadem Hospital Oncology Department" in a lesser frequency.

Most popular intervention types in "Adana Acıbadem Hospital Oncology Department" are "Drug" (10 trials), "Biological" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "Alectinib" (2 trials), "Cisplatin" (2 trials), "Cyclophosphamide" (2 trials) and "Emicizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Adana Acıbadem Hospital Oncology Department" are 13 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Adana Acıbadem Hospital Oncology Department". undefined are not yet recruiting, 7 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Adana Acıbadem Hospital Oncology Department, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Adana Acıbadem Hospital Oncology Department, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".